Cargando…
The Combination of Novel Targeted Molecular Agents and Radiation in the Treatment of Pediatric Gliomas
Brain tumors are the most common solid pediatric malignancy. For high-grade, recurrent, or refractory pediatric brain tumors, radiation therapy (XRT) is an integral treatment modality. In the era of personalized cancer therapy, molecularly targeted agents have been designed to inhibit pathways criti...
Autores principales: | Dasgupta, Tina, Haas-Kogan, Daphne A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650671/ https://www.ncbi.nlm.nih.gov/pubmed/23717811 http://dx.doi.org/10.3389/fonc.2013.00110 |
Ejemplares similares
-
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era
por: Manoharan, Neevika, et al.
Publicado: (2022) -
Combining molecular targeted agents with radiation therapy for malignant gliomas
por: Scaringi, Claudia, et al.
Publicado: (2013) -
Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges
por: Qiu, Bo, et al.
Publicado: (2021) -
Toward an Improved Understanding of the Ionizing Radiation Induced DNA Damage/Response Networks in Human Malignancies
por: Haas-Kogan, Daphne A., et al.
Publicado: (2014) -
Non-Muscle Myosin IIa Heavy Chain Links Squamous-Cell Carcinoma of the Head and Neck to the DNA Damage Response
por: Raleigh, David R., et al.
Publicado: (2014)